GAITHERSBURG, Md., Sept. 22, 2014 (GLOBE NEWSWIRE) -- GlycoMimetics, Inc. (Nasdaq:GLYC) today announced that Rachel King, Chief Executive Officer, will present an overview of the company at BioCentury's 21st Annual Newsmakers in the Biotech Industry Conference on September 26, 2014, at 9:30 a.m. Eastern Time in New York City.
To access the live webcast and subsequent archived recordings for the presentation, please visit the GlycoMimetics website at www.glycomimetics.com.
About GlycoMimetics, Inc.
GlycoMimetics is a clinical stage biotechnology company focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using its expertise in carbohydrate chemistry and knowledge of carbohydrate biology, GlycoMimetics is developing a pipeline of glycomimetic drug candidates that inhibit disease-related functions of carbohydrates, such as the roles they play in inflammation, cancer and infection.
CONTACT: Brian Hahn Email: bhahn@glycomimetics.com Phone: 240-243-1207
